Profilo
Steven E.
Brown worked as the Chief Financial Officer, Treasurer, and VP of Delsite, Inc. from 1980 to 1994.
He then worked as the President and Director of RBC Life Sciences, Inc. from 2014 to 2015, and held other positions at RBC Life Sciences, Inc. until 2020.
Precedenti posizioni note di Steven E. Brown
Società | Posizione | Fine |
---|---|---|
RBC LIFE SCIENCES, INC. | Amministratore Delegato | - |
Delsite, Inc.
Delsite, Inc. Pharmaceuticals: OtherHealth Technology DelSite, Inc. research-based, biopharmaceutical and consumer products company with a core technology based on naturally occurring complex carbohydrates. DelSite is developing its proprietary GelSite technology designed to provide controlled release of peptide and protein-based drugs. More than 130 patents protect its technology. It was incorporated in Texas in 1973, as Carrington Laboratories, Inc. | Direttore Finanziario/CFO | 01/04/1994 |
Delsite, Inc.
Delsite, Inc. Pharmaceuticals: OtherHealth Technology DelSite, Inc. research-based, biopharmaceutical and consumer products company with a core technology based on naturally occurring complex carbohydrates. DelSite is developing its proprietary GelSite technology designed to provide controlled release of peptide and protein-based drugs. More than 130 patents protect its technology. It was incorporated in Texas in 1973, as Carrington Laboratories, Inc. | Direttore Finanziario/CFO | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
RBC LIFE SCIENCES, INC. | Health Technology |
Aziende private | 1 |
---|---|
Delsite, Inc.
Delsite, Inc. Pharmaceuticals: OtherHealth Technology DelSite, Inc. research-based, biopharmaceutical and consumer products company with a core technology based on naturally occurring complex carbohydrates. DelSite is developing its proprietary GelSite technology designed to provide controlled release of peptide and protein-based drugs. More than 130 patents protect its technology. It was incorporated in Texas in 1973, as Carrington Laboratories, Inc. | Health Technology |
- Borsa valori
- Insiders
- Steven E. Brown